TNM Staging for Kidney and Adrenal Gland
Recorded on November 3, 2010 (60 minutes)

 The Seventh Edition Cancer Staging Manual incorporates some significant changes in cancer staging for specific disease sites.  The purpose of this presentation is to highlight the major changes for Kidney and Adrenal Gland including Ipsilateral adrenal involvement reclassification and the simplification of nodal involvement.

Target Audience:  This program is primarily intended for physicians but also open cancer registrars.


Learning Objectives:

1.     Understand the new chapter for Adrenal Gland

2.     Identify the changes for Kidney

3.     Discuss the rationale for the changes

4.     Review prognostic factors 


Financial support for the development of this presentation and webinar has been provided by the American Cancer Society. The information provided here does not necessarily represent the views of the American Cancer Society, Society Staff, or it's Board of Directors. 




 For registration support, please call 1-800-274-9390 or email


If you would like to pay by check or register via telephone, please contact our Customer Support Group at 1-800-274-9390.

The American Cancer Society has provided funding to underwrite the cost of the AJCC webinars beginning in September 2010. The new price is a reflection of their generous financial support.


Steven Campbell, MD, PhD
Cleveland Clinical


Steven Campbell, MD, PhD, is Professor of Surgery, Residency Program Director, and a member of the Section of Urologic Oncology in the Glickman Urological and Kidney Institute at Cleveland Clinic. He obtained his medical degrees at the University of Chicago and completed his urology residency at Cleveland Clinic (1989-1995), followed by a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center (1995-1996).

Dr. Campbell's primary interests include renal cell carcinoma, bladder cancer, prostate cancer, treatment-related osteoporosis and tumor angiogenesis.  His background also includes American Foundation for Urologic Disease (AFUD) and Kimmel Research Scholarship awards, and he is a former member of the American Board of Urology Examination Committee. Dr. Campbell is currently on the educational board for AFUD and the medical advisory board for the Kidney Cancer Association.


Faculty Disclosures

CE Credit:  The National Cancer Registrars Association(NCRA) has determined that this program 2010-099 supports 1.0 CE Hours.

CME Credit: 

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medial education for physicians.

The American College of Surgeons designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity.
Select a Webinar Format:

You must be logged in to add a program to your cart.